Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Drug Evaluation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Breast Neoplasms 2 Thrombocythemia, Essential 1 Polycythemia Vera 1 Lymphedema 1 Liver Neoplasms 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Eunuchism 1 Breast Diseases 1 Adenoma 1

Interventions

Sorafenib 38 Oxaliplatin 21 Bevacizumab 21 Radiosurgery 15 Fluorouracil 15 Gemcitabine 14 Nivolumab 11 Hepatectomy 11 Cisplatin 11 lenvatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Leucovorin 9 Doxorubicin 9 durvalumab 8 Liver Transplantation 8 Blood Specimen Collection 8 atezolizumab 7 Capecitabine 7 pembrolizumab 6 camrelizumab 6 Immunohistochemistry 6 Everolimus 6 Electroporation 6 Cyclophosphamide 6 Cryosurgery 6 tremelimumab 5 sintilimab 5 apatinib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05913141 2023-06-22

PDO/PDO-TIL/PDOTS for Drug Screen

Shanghai Zhongshan Hospital

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡